[Preinvasive lesions in gynaecology -  ovary].

@article{Feranec2013PreinvasiveLI,
  title={[Preinvasive lesions in gynaecology -  ovary].},
  author={R. Feranec and L. Moukov{\'a}},
  journal={Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti},
  year={2013},
  volume={26 Suppl},
  pages={
          S54-5
        }
}
  • R. Feranec, L. Mouková
  • Published 2013
  • Biology, Medicine
  • Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
In comparison to malignant tumors of vulva, vagina, cervix and uterine corpus, clear morphologic and molecular genetic features of precursor lesions of ovarian carcinoma have not been defined yet. We can see an effort to describe preinvasive lesions to allow dia-gnostics and treatment prior to development of invasive ovarian cancer. This tendency is magnified by the fact that ovarian carcinomas have the highest mortality from all gynecological malignancies. Currently, reports confirming… Expand

References

SHOWING 1-10 OF 10 REFERENCES
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
TLDR
This model of carcinogenesis reconciles the relationship of borderline tumors to invasive carcinoma and provides a morphological and molecular framework for studies aimed at elucidating the pathogenesis of ovarian cancer. Expand
Pathogenesis of Ovarian Cancer: Lessons From Morphology and Molecular Biology and Their Clinical Implications
  • R. Kurman, I. Shih
  • Biology, Medicine
  • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • 2008
TLDR
A model of ovarian carcinogenesis is proposed that takes into account the diverse nature of ovarian cancer and correlates the clinical, pathological, and molecular features of the disease, and helps to explain why current screening techniques, aimed at detecting stage I disease, have not been effective. Expand
The cell of origin of ovarian epithelial tumours.
  • L. Dubeau
  • Biology, Medicine
  • The Lancet. Oncology
  • 2008
TLDR
Recent epidemiological and molecular biological findings as well as evidence based on histopathological observations of surgical specimens from individuals with familial ovarian cancer predisposition are discussed, including evidence that primary ovarian epithelial tumours, fallopian tube carcinomas, and primary peritoneal carcinomas are Müllerian in nature. Expand
Histopathologic Features of Genetically Determined Ovarian Cancer
  • P. Shaw, J. McLaughlin, +7 authors I. Jacobs
  • Biology, Medicine
  • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • 2002
TLDR
Ovarian carcinomas associated with germline mutations of BRCA1/BRCA2 are, in this study, invasive serous carcinomas, with a statistically significant higher histologic grade than ovarian carcinomas without BRCa mutations when using the recently proposed Silverberg grading system. Expand
Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
TLDR
Annual gynecological screening of women with a BRCA1/2 mutation to prevent advanced stage ovarian cancer is not effective, and sensitivities and positive predictive values of the screening modalities are low. Expand
Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
  • D. Stirling, D. Evans, +11 authors M. Porteous
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
TLDR
Annual surveillance by transvaginal ultrasound scanning and serum CA-125 measurement in women at increased familial risk of ovarian cancer is ineffective in detecting tumors at a sufficiently early stage to influence prognosis. Expand
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
TLDR
This paper reviews the subject of hereditary ovarian cancer, with particular attention to its molecular genetic basis, its pathology, and its phenotypic/genotypic heterogeneity. Expand
Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11‐year cohort study
TLDR
It is concluded that the efficacy of screening women at high risk of ovarian cancer seems poor because the majority of cancers were detected at an advanced stage. Expand
Současná léčba karcinomu ovaria
  • Acta medicinae 2012;
  • 2012
Effi‐ cacy of screening women at high risk of hereditary ova‐ rian cancer: results of an 11‐year kohort study
  • Int J Gyne‐ col Cancer 2006;
  • 2006